Skip to main content

Table 2 Baseline clinical characteristics of DR-TB patients on second line anti-TB treatment in Amhara region, Ethiopia

From: Time to poor treatment outcome and its predictors among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara region, Ethiopia: retrospective cohort study

VariablesFrequencyPercent
Sputum smear
 Positive40078.5
 Negative10821.5
BMI
  < 18.538876.4
  ≥ 18.512023.6
Co-existing diabetes
 Yes163.1
 No49296.9
CKD
 Yes71.4
 No50198.6
HIV
 Positive12324.2
 Negative38575.8
COPD
 Yes8817.32
 No42082.68
Hemoglobin status
 Anemic39277.2
 Non anemic11622.8
HTN
 Yes152.9
 No49397.1
Previous TB treatment
 Yes40479.5
 No10420.5
Resistant type
 R or H28856.7
 MDR22043.3
TB type
 Pulmonary44788.0
  Disseminate6112.0
Cigarette smoker
 Yes7214.2
 No43685.8
  1. COPD Chronic obstructed pulmonary disease, BMI body mass index, HTN hypertension, HIV human immune virus, CKD chronic kidney disease = refimpsine, H isoniazid, MDR multi drug resistant